Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SI-BONE's iFuse-TORQ OK'ed for Pelvic Fractures - Orthopedic Design & Technology
OEM News

SI-BONE’s iFuse-TORQ OK’ed for Pelvic Fractures

Indications include acute, non-acute, and non-traumatic fractures.

Sacropelvic medical device firm SI-BONE’s iFuse-TORQ has earned U.S. Food and Drug Administration (FDA) clearance for pelvic fracture fixation, including acute, non-acute, and non-traumatic fractures.
 
Sacral fragility (related to low-energy traumatic events) and insufficiency fractures are common and can be devastating to the healthcare system.
 
“Many elderly patients with sacral fragility fractures require long periods of immobility while their fracture heals, often leading to complications associated with bedrest,” Michael Gardner, MD, Chief of Orthopedic Trauma at Stanford University Hospital told the press. “A paradigm shift is required. The strength and osseointegrative features of iFuse-TORQ make it the most attractive implant on the market to remobilize these osteoporotic patients.”
 
“Since its launch in 2021, iFuse-TORQ has been used to treat many patients suffering from a pelvic fracture or sacroiliac joint dysfunction,” said Laura Francis, CEO of SI-BONE. “This pelvic fracture fixation indication expansion comes on the coattails of the iFuse Bedrock Granite launch and expands SI-BONE’s position as the market leader in the sacropelvic space.”

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters